Screener
CorMedix CRMD Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: CorMedix’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Accounts payable | $12,827 | $7,884 |
| Accrued expenses and other liabilities | 112,773 | 163,370 |
| Contingent Consideration, short-term | 3,176 | 3,015 |
| Total current liabilities | 128,776 | 174,269 |
| Convertible senior notes, net of deferred financing costs | 144,885 | 144,626 |
| Contingent Consideration, net of current portion | 102,397 | 99,101 |
| Other long-term liabilities | 2,530 | 2,839 |
| TOTAL LIABILITIES | $378,588 | $420,835 |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is CorMedix's total current liabilities?
- CorMedix (CRMD) reported total current liabilities of $128.78M in Q1 2026.
- How has CorMedix's total current liabilities changed year-over-year?
- CorMedix's total current liabilities increased by 274.5% year-over-year, from $34.39M to $128.78M.
- What is the long-term trend for CorMedix's total current liabilities?
- Over 5 years (2020 to 2025), CorMedix's total current liabilities has grown at a 111.1% compound annual growth rate (CAGR), from $4.16M to $174.27M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about CorMedix's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude